Geode Capital Management’s Monopar Therapeutics MNPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.47M | Buy |
96,919
+48,379
| +100% | +$1.73M | ﹤0.01% | 2914 |
|
|
2025
Q1 | $1.77M | Buy |
48,540
+9,944
| +26% | +$362K | ﹤0.01% | 3086 |
|
|
2024
Q4 | $849K | Buy |
38,596
+24,530
| +174% | +$540K | ﹤0.01% | 3426 |
|
|
2024
Q3 | $94.8K | Sell |
14,066
-45,970
| -77% | -$310K | ﹤0.01% | 4118 |
|
|
2024
Q2 | $44.9K | Buy |
60,036
+18,837
| +46% | +$14.1K | ﹤0.01% | 4303 |
|
|
2024
Q1 | $28.1K | Hold |
41,199
| – | – | ﹤0.01% | 4430 |
|
|
2023
Q4 | $14K | Hold |
41,199
| – | – | ﹤0.01% | 4561 |
|
|
2023
Q3 | $23.5K | Sell |
41,199
-693
| -2% | -$395 | ﹤0.01% | 4589 |
|
|
2023
Q2 | $35.8K | Hold |
41,892
| – | – | ﹤0.01% | 4575 |
|
|
2023
Q1 | $59.5K | Hold |
41,892
| – | – | ﹤0.01% | 4477 |
|
|
2022
Q4 | $99K | Buy |
41,892
+2,721
| +7% | +$6.43K | ﹤0.01% | 4407 |
|
|
2022
Q3 | $59K | Hold |
39,171
| – | – | ﹤0.01% | 4730 |
|
|
2022
Q2 | $85K | Hold |
39,171
| – | – | ﹤0.01% | 4645 |
|
|
2022
Q1 | $100K | Hold |
39,171
| – | – | ﹤0.01% | 4662 |
|
|
2021
Q4 | $126K | Hold |
39,171
| – | – | ﹤0.01% | 4650 |
|
|
2021
Q3 | $189K | Buy |
39,171
+10,410
| +36% | +$50.2K | ﹤0.01% | 4475 |
|
|
2021
Q2 | $169K | Buy |
28,761
+2,367
| +9% | +$13.9K | ﹤0.01% | 4399 |
|
|
2021
Q1 | $163K | Buy |
+26,394
| New | +$163K | ﹤0.01% | 4176 |
|